Reference Source

Nanjing Maohai Biotech Co. · 66-40 · CHINA

For Nanjing Maohai Biotech Co. · 66-40 · CHINA, import alert is 66-40; import alert name is "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"; country is CHINA; product is Crude Heparin (Pharmaceutical Necessity) | Heparin Sodium (Anti-Coagulant); product code is 55 R - - 75 Crude Heparin (Pharmaceutic Necessity) | 61 L - - 08 Heparin Sodium (Anti-Coagulant); date published is 10/18/2011; address is 8 Yaxi , Town, Gaochun County , Nanjing, Jiangsu Province CHINA, verified against its source on 2026-09-16.

Firm
Nanjing Maohai Biotech Co. verified
Import alert
66-40
Import alert name
"Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"
Country
CHINA verified
Address
8 Yaxi , Town, Gaochun County , Nanjing, Jiangsu Province CHINA verified
Date published
10/18/2011 verified
Product code
55 R - - 75 Crude Heparin (Pharmaceutic Necessity) | 61 L - - 08 Heparin Sodium (Anti-Coagulant) each item verified
Product
Crude Heparin (Pharmaceutical Necessity) | Heparin Sodium (Anti-Coagulant) each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Nanjing Maohai Biotech Co. Date Published : 10/18/2011 8 Yaxi , Town, Gaochun County , Nanjing, Jiangsu Province CHINA 55 R - - 75 Crude Heparin (Pharmaceutic Necessity) Date Published: 10/18/2011 Desc: Crude Heparin (Pharmaceutical Necessity) 61 L - - 08 Heparin Sodium (Anti-Coagulant) Date Published: 10/18/2011 Desc: Heparin Sodium (Anti-Coagulant)

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.